Neil Vasan MD

Summary

• Neil Vasan, MD, PhD, is a breast oncologist, physician scientist, Assistant Professor of Medicine, and Director of Translational Research in Breast Cancer at the NYU Grossman School of Medicine and Perlmutter Cancer Center at NYU Langone Health. His laboratory (vasanlab.org) studies how kinases and other enzymes regulate breast cancer cell signaling, growth, and therapeutic response.
  
  Neil received his AB/AM from Harvard University and his MD/PhD from Yale University School of Medicine, and he completed clinical training in internal medicine at MGH and in medical oncology at MSKCC. As a postdoctoral fellow, he identified double PIK3CA mutations as an oncogenic alteration, which has gone from bench to bedside as a cancer genomic biomarker. Prior to NYU, he held previous faculty positions at MSKCC and Columbia University Irving Medical Center.
  
  His research awards include the 2023 NIH Director's New Innovator Award (DP2), Susan G. Komen Career Catalyst Research grant, American Association for Cancer Research (AACR) NextGen Star, and American Society for Clinical Investigation (ASCI) Young Physician-Scientist Award. Neil is the Scientific Advisor for PIK3CA Pathbreakers, a breast cancer patient advocacy group. He also serves as a Standing Member of the Oncologic Drugs Advisory Committee (ODAC) for the FDA.